On Friday, Insmed Inc (NASDAQ: INSM) opened higher 1.48% from the last session, before settling in for the closing price of $69.41. Price fluctuations for INSM have ranged from $21.92 to $80.53 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 275.45% over the last five years. Company’s average yearly earnings per share was noted -0.69% at the time writing. With a float of $174.61 million, this company’s outstanding shares have now reached $178.85 million.
The firm has a total of 912 workers. Let’s measure their productivity. In terms of profitability, gross margin is 76.51%, operating margin of -214.11%, and the pretax margin is -251.01%.
Insmed Inc (INSM) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Insmed Inc is 2.40%, while institutional ownership is 105.29%. The most recent insider transaction that took place on Dec 19 ’24, was worth 1,310,799. In this transaction Chair and CEO of this company sold 18,750 shares at a rate of $69.91, taking the stock ownership to the 384,960 shares. Before that another transaction happened on Dec 19 ’24, when Company’s Chair and CEO sold 6,830 for $69.92, making the entire transaction worth $477,550. This insider now owns 233,924 shares in total.
Insmed Inc (INSM) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.69% per share during the next fiscal year.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Check out the current performance indicators for Insmed Inc (INSM). In the past quarter, the stock posted a quick ratio of 5.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 37.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.56, a number that is poised to hit -1.18 in the next quarter and is forecasted to reach -4.34 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Analysing the last 5-days average volume posted by the [Insmed Inc, INSM], we can find that recorded value of 2.87 million was better than the volume posted last year of 2.22 million. As of the previous 9 days, the stock’s Stochastic %D was 17.58%. Additionally, its Average True Range was 2.83.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 35.61%, which indicates a significant increase from 17.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.76% in the past 14 days, which was lower than the 39.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $72.34, while its 200-day Moving Average is $58.79. Now, the first resistance to watch is $71.41. This is followed by the second major resistance level at $72.37. The third major resistance level sits at $73.68. If the price goes on to break the first support level at $69.14, it is likely to go to the next support level at $67.83. Now, if the price goes above the second support level, the third support stands at $66.87.
Insmed Inc (NASDAQ: INSM) Key Stats
There are currently 178,903K shares outstanding in the company with a market cap of 12.79 billion. Presently, the company’s annual sales total 305,210 K according to its annual income of -749,570 K. Last quarter, the company’s sales amounted to 93,430 K and its income totaled -220,520 K.
